1.Application of Da Vinci surgical system in distal pancreatic tumor resection
Longyue WANG ; Weihong DUAN ; Zhenyu ZHU ; Junzhou CHEN ; Tao ZHANG ; Ningxin ZHOU
Chinese Journal of Postgraduates of Medicine 2013;(8):10-13
Objective To explore the clinical safety and validity of Da Vinci surgical system in distal pancreatic tumor resection.Methods The clinical data of 14 patients with distal pancreatic tumor underwent robotic surgeries by using Da Vinci surgical system from January 2009 to June 2012 were retrospectively analyzed.Results The average operation time was 343.93 (170-575) min,average blood loss was 192.5 (10-700) ml,without blood trahsfusion.Pathologic examination showed:pancreatic ductal adenocarcinoma in 7 patients,pancreatic cystadenoma in 1 patient,mucous cystadenoma in 1 patient,cystadenocarcinoma in 1 patient,high levels of pancreatic ductal intraepithelial neoplasia in 1 patient,insulinoma in 1 patient,solid pseudo-papillary tumor in 2 patients.Two patients with pancreatic leaks after operation and then relieved after conservative medical therapy.Others were discharged from hospital without complications.The average hospital stay was 10.64 d.Conclusions Da Vinci surgical system is safe and effective in treatment for patients with distal pancreatic rumor with minimally invasive advantage.Because lack of surgical experience and small sample,a large sample with long term follow-up of high-quality clinical research is required and then update the system to evaluate the efficacy and safety.
2.Experiences of nasal reconstruction with forehead flap: reports of 13 cases.
Siquan TANG ; Jun FENG ; Jinsong WEN ; Ping LÜ ; Yanli HUANG ; Hongying PU ; Jianhui ZHANG ; Bei LI ; Tianming ZHOU ; Longyue LIU ; Bifeng WANG ; Zhaohua CHE
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2007;21(5):202-203
OBJECTIVE:
To present the experience of nasal reconstruction with forehead flap.
METHOD:
nasal reconstruction with forehead flap were applied in eight nasal carcinoma cases after operation and 5 nasal trauma cases with defects.
RESULT:
These forehead flaps were alive in all patients, all incision healed in I stage, no post operative complications were found. The shapes of nose were satisfactory, there were no recurrence of tumor during 1 to 17 year follow up.
CONCLUSION
The method can be clinically applied for its simple procedure, reliable flap's blood supply, high survival rate and satisfied result.
Adolescent
;
Adult
;
Aged
;
Female
;
Forehead
;
surgery
;
Humans
;
Male
;
Middle Aged
;
Nose
;
injuries
;
surgery
;
Rhinoplasty
;
methods
;
Skin Transplantation
;
Surgical Flaps
;
Young Adult
3.Effects of Yiru tiaojing granules on the pharmacokinetics of olanzapine in rats
Huihui ZHENG ; Longyue ZHOU ; Boxin ZHAO ; Chunxia WANG
China Pharmacy 2023;34(18):2182-2186
OBJECTIVE To investigate the effects of Yiru tiaojing granules on the pharmacokinetics of olanzapine in rats. METHODS SD rats were randomly divided into 4 groups according to single-dose administration and multiple-dose administration, with 6 rats in each group. Groups A and B were given olanzapine (5 mg/kg) or olanzapine (5 mg/kg)+Yiru tiaojing granules (0.972 g/kg) in a single gavage, and groups C and D were administered with the same method once a day for 14 d. Blood was collected from the orbital venous plexus before administration and 5, 15, 30 min and 1, 2, 3, 6, 8, 12, 24 h after the last administration, respectively. The blood concentration was determined by LC-MS, and the pharmacokinetic parameters were calculated by using DAS 2.0 software. RESULTS Compared with group A, group B showed a significant decrease in AUC0-24 h, AUC0-∞ and cmax (P<0.05), and a significant prolongation of MRT0-24 h, MRT0-∞ and CLz/F (P<0.05); there was no statistically significant difference in the pharmacokinetic parameters between group C and group D (P>0.05). CONCLUSIONS A single administration of Yiru tiaojing granules can inhibit the absorption of olanzapine in rats, and long-term administration of Yiru tiaojing granules does not have a significant effect on the pharmacokinetic process of olanzapine.